经典霍奇金淋巴瘤治疗后非霍奇金淋巴瘤:德国霍奇金研究组报告
Data on non-Hodgkin lymphoma (NHL) after classical Hodgkin lymphoma (cHL) are scarce. We therefore performed a retrospective analysis comprising 11·841 cHL patients who had first-line treatment within the randomized German Hodgkin Study Group (GHSG) HD7-HD15 studies.…
要点
- 中位发生时间44个月,中位诊断年龄54岁,需关注治疗后早期及老年人群。
核心结论
- 经典霍奇金淋巴瘤治疗后非霍奇金淋巴瘤是罕见事件,主要影响老年个体且常导致患者死亡。
主要发现
- 非霍奇金淋巴瘤的中位发生时间为44个月,诊断时中位年龄54岁。
临床怎么用
- 经典霍奇金淋巴瘤治疗后需警惕非霍奇金淋巴瘤发生,尤其对老年患者及治疗后早期进行监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Data on non-Hodgkin lymphoma (NHL) after classical Hodgkin lymphoma (cHL) are scarce. We therefore performed a retrospective analysis comprising 11·841 cHL patients who had first-line treatment within the randomized German Hodgkin Study Group (GHSG) HD7-HD15 studies. After a median follow-up of 106 months, 175 patients (1·5%) had developed NHL. The median time to NHL was 44 months, the median age at NHL diagnosis was 54 years. The five-year event-free survival and overall survival estimates from the diagnosis of NHL were 36·9% and 44·2%, respectively. Thus, NHL after cHL is a rare event primarily affecting older individuals and often resulting in the patient´s death.
引用
- Eichenauer DA, Müller H, Elger L, et al. Non-Hodgkin lymphoma after treatment for classical Hodgkin lymphoma: a report from the German Hodgkin Study Group. Br J Haematol. 2021. PMID: 33486762. doi:10.1111/bjh.17327
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。